ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
34 announcements
Dr. Agarwal’s Health Care received NCLT approval to convene shareholder and creditor meetings regarding its amalgamation with AEHL. Meetings are scheduled for July 02, 2026.
Dr. Agarwal's Health Care Limited allotted 1,50,282 equity shares under its ESOP/ESPS scheme. This increased the company's paid-up share capital from 31,68,07,506 to 31,69,57,788. Such allotments align employee interests with corporate performance and lead to a marginal expansion of the equity base.
Dr. Agarwal's Health Care Ltd allotted 1,50,282 equity shares valued at approximately ₹1.95 Crore following the exercise of employee stock options. This allotment increases the company's paid-up equity share capital to ₹31.69 Crore.
Dr. Agarwal's Health Care Limited submitted the Regulation 74(5) compliance certificate for the quarter ended March 31, 2026. Issued by KFin Technologies Limited, the certificate confirms that securities dematerialisation and rematerialisation details have been furnished to the stock exchanges. This is a routine regulatory filing with no material impact on operations.